Phase II Trial with Gemcitabine, Paclitaxel and Bevacizumab for the First Line Treatment of Metastatic Breast Cancer.

2009 ◽  
Author(s):  
A. Guardino ◽  
M. Chen ◽  
M. Levy ◽  
C. Chen
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer

2010 ◽  
Vol 28 (9) ◽  
pp. 925-931 ◽  
Author(s):  
Denise A. Yardley ◽  
Michael McCleod ◽  
Fred Schreiber ◽  
Patrick Murphy ◽  
Jeffrey Patton ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Phase II trial of weekly nab-paclitaxel in combination with bevacizumab as first-line treatment in metastatic breast cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 1075-1075 ◽  
Author(s):  
M. A. Danso ◽  
J. L. Blum ◽  
N. J. Robert ◽  
L. Krekow ◽  
R. Rotche ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Phase II Trial of Weekly Docetaxel, Vinorelbine, and Trastuzumab in the First-Line Treatment of Patients with HER2-Positive Metastatic Breast Cancer

2009 ◽  
Vol 9 (1) ◽  
pp. 23-28 ◽  
Author(s):  
Jeffrey R. Infante ◽  
Denise A. Yardley ◽  
Howard A. Burris ◽  
F. Anthony Greco ◽  
Cindy P. Farley ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Line Treatment ◽  
First Line ◽  
Her2 Positive ◽  
Weekly Docetaxel ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document